Loading organizations...
§ Private Profile · 1001-1002 10th Floor Zhongguancun Capital Building No. 62 Xueyuan S Haidian District Rd, Beijing, Beijing, China
Develops enterprise AI platforms and solutions for businesses, focused on enhancing operational efficiency and data intelligence.
Based in Beijing, China, DEEPEXI develops enterprise-grade artificial intelligence and business intelligence software solutions that integrate big data and generative AI to enhance corporate operational decision-making. The enterprise SaaS provider operates with a workforce of 363 employees and generates approximately $96 million in revenue, despite recording net losses exceeding RMB 2.4 billion over the past three years. Having raised between $150 million and $270 million in total capital across multiple funding rounds up to the Series B-II stage, the company recently filed for an initial public offering in Hong Kong. The firm's public market debut is being sponsored by major financial institutions including CITIC Securities and Minsheng Capital, while its leadership draws on prior executive experience at technology giants Huawei and Alibaba Cloud. DEEPEXI was founded in 2018 by Jiehui Zhao and Lei Yang.
DEEPEXI has raised $335.0M across 5 funding rounds.
DEEPEXI has raised $335.0M in total across 5 funding rounds.
DEEPEXI has raised $335.0M in total across 5 funding rounds.
DEEPEXI's investors include 5Y Capital, Granite Asia, Shunwei Capital, Highland Capital Partners, Sichuan Xintai, BAI Capital, Jiangchuan Tian, China Merchants Capital, Yinchuan Xu, IDG Capital.
DEEPEXI has raised $335.0M across 5 funding rounds. Most recently, it raised $110.0M Series B in July 2022.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jul 5, 2022 | $110M Series B | — | — | Announced |
| Aug 20, 2021 | $100M Venture Round | — | — | Announced |
| Dec 1, 2020 | $40M Series A | — | 5Y Capital, Granite Asia, Shunwei Capital | Announced |
| May 1, 2020 | $50M Series A | Highland Capital Partners, Sichuan Xintai | 5Y Capital, Granite Asia, Shunwei Capital, BAI Capital, Jiangchuan Tian, China Merchants Capital, Yinchuan XU, IDG Capital | Announced |
| Sep 1, 2019 | $35M Series A | — | 5Y Capital, Granite Asia, Shunwei Capital | Announced |
Deepexi Technology Co., Ltd. is a China-based AI company founded in 2018 that develops enterprise large-model AI application solutions to enhance operational efficiency across industries like consumer goods, manufacturing, healthcare, and transportation.[1][2] It operates two core platforms: the FastData Foil Data Fusion Platform, which processes structured and unstructured data, and the Deepexi Enterprise Large Model Platform, which powers AI-driven decision-making, automation, and agentic applications; these are offered as software solutions and cloud services, either standalone or integrated.[2][3] Serving enterprises, Deepexi solves data silos, workflow inefficiencies, and decision delays with its proprietary large model—the first general-purpose enterprise operational decision-making model to complete dual regulatory filings for deep synthesis and generative AI in China—backed by over 40 patents and contributions to national AI/industrial standards.[1] Recently listed on the Hong Kong Stock Exchange (HKSE: 1384) via IPO on October 28, 2025, raising ~USD 91 million at a ~USD 1.12 billion valuation, it shows growth momentum amid AI adoption but faced a 102% earnings decline last year.[3][4]
Deepexi Technology was established in 2018 in Beijing's Haidian District as an enterprise AI specialist, quickly earning recognition as a National Specialised and Innovative “Little Giant” Enterprise.[1][2] While specific founder details are not detailed in available sources, the company emerged during China's accelerating AI push, focusing on large-model applications for industrial use; early milestones include developing over 40 registered patents and drafting national standards in AI and industrial tech.[1] A pivotal moment was creating the industry's first enterprise operational decision-making large model with dual regulatory approvals for deep synthesis algorithms and GenAI services, enabling compliant, scalable deployments.[1] This foundation propelled its path to public listing on HKEX in late 2025, underwritten by firms like BOCOM International and CLSA.[3]
Deepexi rides China's enterprise AI wave, where large models address data explosion and automation needs amid industrial digitization and "Made in China 2025" initiatives.[1][3] Timing aligns with global GenAI hype post-2023, but its edge lies in China-specific regulatory navigation—dual filings enable trust in sensitive sectors like healthcare/transport, where Western models face barriers.[1] Market forces favoring it include surging demand for agentic AI (autonomous agents handling complex tasks) and data fusion in fragmented enterprise environments, plus government support for "Little Giants" like Deepexi.[1][3] It influences the ecosystem by standardizing enterprise AI practices, fostering compliant innovation that scales domestically and potentially regionally via HKEX visibility.[1][3]
Deepexi's post-IPO trajectory hinges on reversing earnings declines through platform adoption and GenAI monetization, targeting deeper penetration in high-growth sectors like manufacturing and healthcare.[4] Trends like agentic AI evolution, multimodal data fusion, and China’s push for sovereign AI stacks will shape it, potentially expanding to edge computing or international markets if regulations ease.[1][2][3] Its influence may grow as a benchmark for compliant enterprise models, evolving from "Little Giant" to mid-cap AI leader—watch for revenue acceleration via cloud subscriptions and partnerships, tying back to its core strength in turning regulatory hurdles into competitive moats.[1][3][4]